for educational and safety purposes
Every compound in the sci-wiki that affects monoamine reuptake; the ones you can source are floated to the front, then the reference-only entries. Tap any for the full entry, mechanism, and outlets.
1 sourced · 1 reference
Pregabalin with nortriptyline and methylcobalamin is a fixed-dose combination product used mainly for nerve pain, particularly the painful diabetic peripheral neuropathy commonly treated in South Asia, where such combinations are widely marketed. It brings together three ingredients with different roles: pregabalin, a gabapentinoid that calms overactive nerve signalling; nortriptyline, a tricyclic antidepressant long used for neuropathic pain; and methylcobalamin, an active form of vitamin B12 involved in nerve health. It is not sold as a single approved medicine in regions such as the United States or Europe, and the supporting evidence comes largely from studies of its individual components.
Besipirdine was Hoechst-Roussel's attempt to broaden the cholinergic-hypothesis playbook for Alzheimer's disease by hitting two neurotransmitter systems at once, enhancing both cholinergic and noradrenergic transmission rather than acetylcholine alone, on the theory that a dual mechanism might outperform pure cholinesterase inhibitors. In a 275-patient trial, patients on besipirdine held steady on cognitive testing over three months while the placebo group declined, a genuinely encouraging signal for a still-experimental Alzheimer's drug in the mid-1990s. That promise collapsed in Phase III, where a subset of patients developed serious cardiovascular side effects, forcing Hoechst-Roussel to abandon the program; the company had also explored besipirdine for other indications, including multiple sclerosis-related walking impairment, but none of it reached market.